Veradermics (MANE) Current Assets (2024 - 2026)

Veradermics (MANE) has 3 years of Current Assets data on file, last reported at $397.1 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets changed N/A year-over-year to $397.1 million; the trailing twelve-month figure through Mar 2026 stood at $397.1 million (changed N/A YoY), and the FY2025 full-year result was $152.5 million, up 174.59% from the prior year.
• Current Assets for Q1 2026 stood at $397.1 million, up from $152.5 million in the prior quarter.
• Across five years, Current Assets topped out at $397.1 million in Q1 2026 and bottomed at $55.5 million in Q4 2024.
• The 3-year median for Current Assets is $152.5 million (2025), against an average of $201.7 million.
• Peak annual rise in Current Assets reached 174.59% in 2025, while the deepest fall reached 174.59% in 2025.
• A 3-year view of Current Assets shows it stood at $55.5 million in 2024, then jumped by 174.59% to $152.5 million in 2025, then jumped by 160.38% to $397.1 million in 2026.
• The last three Current Assets figures came in at $397.1 million (Q1 2026), $152.5 million (Q4 2025), and $55.5 million (Q4 2024), per Business Quant data.

Peer Comparison